Europe Overactive Bladder Treatment Market : Table of Contents

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Overactive Bladder Treatment Market– By Pharmacotherapy

1.3.2 Europe Overactive Bladder Treatment Market– By Disease Type

1.3.3 Europe Overactive Bladder Treatment Market – By Country

2. Europe Overactive Bladder Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Overactive Bladder Treatment Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Expert Opinion

5. Europe Overactive Bladder Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Urinary Incontinence

5.1.2 Growing Incidence of Urinary Tract Infections

5.2 Key Market Restraints

5.2.1 Recalls of Therapeutic Drugs

5.3 Key Market Opportunities

5.3.1 Increasing Number of Mergers and Acquisitions

5.4 Future Trends

5.4.1 Robust Pipeline of Drugs and Successive Launch of Novel Therapies

5.5 Impact analysis

6. Europe Overactive Bladder Treatment Market – Europe Analysis

6.1 Europe Overactive Bladder Treatment Market Revenue Forecast and Analysis

7. Europe Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Pharmacotherapy

7.1 Overview

7.2 Europe Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)

7.3 Mirabegron

7.3.1 Overview

7.3.2 Mirabegron: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.4 Botox

7.4.1 Overview

7.4.2 Botox: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.5 Neurostimulation

7.5.1 Overview

7.5.2 Neurostimulation: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.3 Transcutaneous Sacral Nerve Stimulation

7.5.3.1 Overview

7.5.3.2 Transcutaneous Sacral Nerve Stimulation: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.4 Transcutaneous Tibial Nerve Stimulation

7.5.4.1 Overview

7.5.4.2 Transcutaneous Tibial Nerve Stimulation: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.5 Percutaneous Posterior Tibial Nerve Stimulation

7.5.5.1 Overview

7.5.5.2 Percutaneous Posterior Tibial Nerve Stimulation: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.6 Others

7.5.6.1 Overview

7.5.6.2 Others: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.6 Anticholinergics

7.6.1 Overview

7.6.2 Anticholinergics: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.3 Solifenacin

7.6.3.1 Overview

7.6.3.2 Solifenacin: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.4 Oxybutynin

7.6.4.1 Overview

7.6.4.2 Oxybutynin: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.5 Fesoterodine

7.6.5.1 Overview

7.6.5.2 Fesoterodine: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.6 Darifenacin

7.6.6.1 Overview

7.6.6.2 Darifenacin: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.7 Tolterodine

7.6.7.1 Overview

7.6.7.2 Tolterodine: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.8 Trospium

7.6.8.1 Overview

7.6.8.2 Trospium: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.9 Other Anticholinergics

7.6.9.1 Overview

7.6.9.2 Other Anticholinergics: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.7 Intravesical Instillation

7.7.1 Overview

7.7.2 Intravesical Instillation: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8. Europe Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Disease Type

8.1 Overview

8.2 Europe Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)

8.3 Idiopathic Overactive Bladder

8.3.1 Overview

8.3.2 Idiopathic: Europe Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Neurogenic Overactive Bladder

8.4.1 Overview

8.4.2 Neurogenic: Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 – Country Analysis

9.1 Overview

9.1.2 Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.1.2.1 UK: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.1 UK: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.2 UK: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.2.1 UK: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.2.2 UK: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.1.2.1.3 UK: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2 Germany: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.1 Germany: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.2 Germany: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.2.1 Germany: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.2.2 Germany: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.1.2.2.3 Germany: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3 France: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.1 France: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.2 France: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.2.1 France: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.2.2 France: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.1.2.3.3 France: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.1.2.4 Italy: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.4.1 Italy: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.4.2 Italy: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.2.4.2.1 Italy: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.1.2.4.2.2 Italy: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.1.2.4.3 Italy: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.1.2.5 Spain: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.5.1 Spain: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.5.2 Spain: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.2.5.2.1 Spain: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.1.2.5.2.2 Spain: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.1.2.5.3 Spain: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

9.1.2.6 Rest of Europe: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.6.1 Rest of Europe: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.2.6.2 Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

9.1.2.6.2.1 Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

9.1.2.6.2.2 Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

9.1.2.6.3 Rest of Europe: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

10. Overactive Bladder Treatment Market– Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

11. Company Profiles

11.1 Alembic Pharmaceuticals Limited

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Astellas Pharma Inc

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 AbbVie Inc

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Teva Pharmaceutical Industries Ltd

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Endo Pharmaceuticals Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Hisamitsu Pharmaceutical Co.,Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Medtronic Plc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Pfizer Inc

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES

Table 1. UK: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 2. UK: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 3. UK: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 4. UK: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. Germany: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 6. Germany: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 7. Germany: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 8. Germany: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. France: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 10. France: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 11. France: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 12. France: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 13. Italy: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 14. Italy: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 15. Italy: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 16. Italy: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 17. Spain: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 18. Spain: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 19. Spain: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 20. Spain: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 21. Rest of Europe: Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 22. Rest of Europe: Overactive Bladder Treatment Market, by Anticholinergics – Revenue and Forecast to 2028 (US$ Million)

Table 23. Rest of Europe: Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 24. Rest of Europe: Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 25. Organic Developments Done by Companies

Table 26. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Overactive Bladder Treatment Market Segmentation

Figure 2. Europe Overactive Bladder Treatment Market Segmentation, By Country

Figure 3. Europe Overactive Bladder Treatment Market Overview

Figure 4. Mirabegron Segment Held Largest Share by Pharmacotherapy in Europe Overactive Bladder Treatment market

Figure 5. UK Is Expected to Show Remarkable Growth During the Forecast Period

Figure 7. Europe: PEST Analysis

Figure 8. Europe Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints

Figure 9. Europe Overactive Bladder Treatment Market – Revenue Forecast and Analysis – 2019- 2028

Figure 10. Europe Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)

Figure 11. Mirabegron: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Botox: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Neurostimulation: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Transcutaneous Sacral Nerve Stimulation: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Transcutaneous Tibial Nerve Stimulation: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ MN)

Figure 16. Percutaneous Posterior Tibial Nerve: Europe Overactive Bladder Stimulation Market Revenue and Forecasts To 2028 (US$ MN)

Figure 17. Others: Europe Overactive Bladder Market Revenue and Forecasts To 2028 (US$ MN)

Figure 18. Anticholinergics: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Solifenacin: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Oxybutynin: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Fesoterodine: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Darifenacin: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Tolterodine: Europe Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. Trospium: Europe Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Other Anticholinergics: Europe Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. Intravesical Instillation: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. Europe Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)

Figure 28. Idiopathic: Europe Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Neurogenic: Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. Europe: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 31. Europe: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

Figure 32. UK: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Germany: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. France: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Italy: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Spain: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Rest of Europe: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)